Drug Profile
Research programme: CCR6 pathway modulators - Biokine
Alternative Names: BKT150Latest Information Update: 29 Jan 2016
Price :
$50
*
At a glance
- Originator Biokine Therapeutics
- Class
- Mechanism of Action Chemokine modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Autoimmune disorders; Cancer
Most Recent Events
- 29 Jan 2016 Discontinued for Autoimmune disorders in Israel (IV)
- 29 Jan 2016 Discontinued for Cancer in Israel (IV)
- 07 Jul 2011 Early research in Autoimmune disorders in Israel (IV)